SEC Filings | Sana Biotechnology, Inc

Filing date	Description	Form	View
Apr 26, 2022	Additional proxy soliciting materials - definitive	DEFA14A	0001193125-22-118708.pdf 0001193125-22-118708.rtf View HTML
Apr 28, 2023	Additional proxy soliciting materials - definitive	DEFA14A	0001193125-23-123978.pdf 0001193125-23-123978.rtf View HTML
Apr 26, 2024	Additional proxy soliciting materials - definitive	DEFA14A	0001193125-24-115456.pdf 0001193125-24-115456.rtf View HTML
Nov 10, 2020	Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy	DRS	0000950123-20-011218.pdf 0000950123-20-011218.rtf 0000950123-20-011218.xls View HTML
Dec 18, 2020	Amendment to a previously filed DRS	DRS/A	0000950123-20-012753.pdf 0000950123-20-012753.rtf 0000950123-20-012753.xls View HTML
Feb 03, 2021	EFFECT	EFFECT	9999999995-21-000413.pdf 9999999995-21-000413.rtf 9999999995-21-000413.xls View HTML
May 01, 2023	EFFECT	EFFECT	9999999995-23-001167.pdf 9999999995-23-001167.rtf 9999999995-23-001167.xls View HTML
Feb 08, 2024	FWP	FWP	0001193125-24-027181.pdf 0001193125-24-027181.rtf View HTML
Mar 16, 2023	Post-effective amendment to an S-Type filing	POS AM	0001193125-23-072746.pdf 0001193125-23-072746.rtf 0001193125-23-072746.xls View HTML
May 01, 2023	POS EX	POS EX	0001193125-23-130383.pdf 0001193125-23-130383.rtf 0001193125-23-130383.xls View HTML

Data provided by Kaleidoscope.